AKT1 and Hepatic fibrosis: In addition, miR-200s, which can directly bind p85 α and inhibit the activation of the PI3K/Akt pathway through Fog2, can lead to HSC growth and migration, serving as a potential marker for HSC activation and liver fibrosis progression20.